Comparison of the Abbott Realtime™ HIV-1 and HCV viral load assays with commercial competitor assays

Expert Review of Molecular Diagnostics

Volumn 8, Issue 4, 2008, Pages 369-377

  Schutten, Martin ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Automated system; HCV; HIV 1; Real time RT PCR; Viral load monitoring

Indexed keywords

ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC PROCEDURE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LABORATORY DIAGNOSIS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD;

HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 46949096989     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.8.4.369     Document Type: Article

References (41)

1. Mellors JW, Rinaldo CR Jr, Gupta P et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272(5265), 1167-1170 (1996).
2. van Esser JW, van der HB, Meijer E et al. Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT. Blood 98(4), 972-978 (2001).
3. van Esser JW, Niesters HG, van der Holt B et al. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 99(12), 4364-4369 (2002).
4. van der Ende ME, Prins JM, Brinkman K et al. Clinical, immunological and virological response to different antiretroviral regimens in a cohort of HIV-2-infected patients. AIDS 17(Suppl. 3),S55-S61 (2003).
5. Gazzard B, Bernard AJ, Boffito M et al. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med. 7(8), 487-503 (2006).
6. Yee HS, Currie SL, Darling JM, Wright TL. Management and treatment of hepatitis C viral infection: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center program and the National Hepatitis C Program office. Am. J. Gastroenterol. 101(10), 2360-2378 (2006).
7. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm. Rep. 55(RR-11), 1-94(2006).
8. Abbott MA, Poiesz BJ, Byrne BC et al. Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J. Infect. Dis. 158(6), 1158-1169(1988).
9. Compton J. Nucleic acid sequence-based amplification. Nature 350(6313), 91-92 (1991).
10. de Baar MP, van Dooren MW, de Rooij E et al. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type 1 isolates from groups M, N, and O. J. Clin. Microbiol. 39(4), 1378-1384 (2001).
11. Dewar RL, Highbarger HC, Sarmiento MD et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170(5), 1172-1179(1994).
12. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 339(6221), 237-238 (1989).
13. Schutten M, Peters D, Back NK et al. Multicenter evaluation of the new Abbott Realtime assays for quantitative detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J. Clin. Microbiol. 45(6), 1712-1717(2007).
14. Schutten M, Niesters HG. Clinical utility of viral quantification as a tool for disease monitoring. Expert Rev. Mol. Diagn. 1(2), 153-162(2001).
15. Beuselinck K, Van Ranst M, van Eldere J. Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR. J. Clin. Microbiol. 43(11), 5541-5546 (2005).
16. Sabato MF, Shiffman ML, Langley MR, Wilkinson DS, Ferreira-Gonzalez A. Comparison of the performance characteristics of three real-time RT-PCR test systems for detection and quantification of hepatitis C virus. J. Clin. Microbiol. 45(8), 2529-2536 (2007).
17. Highbarger HC, Hu Z, Kottilil S et al. Comparison of the Abbott 7000 and Bayer 340 systems for measurement of hepatitis C virus load. J. Clin. Microbiol. 45(9), 2808-2812 (2007).
18. Colucci G, Ferguson J, Harkleroad C et al. Improved COBAS Taqman hepatitis C virus test (version 2.0) for use with the High Pure System: enhanced genotype inclusivity and performance characteristics in a multiside study. J. Clin. Microbiol. 45(11), 3595-3600(2007).
19. Luk KC, Devare SG, Hackett JR Jr. Partially double-stranded linear DNA probes: novel design for sensitive detection of genetically polymorphic targets. J. Virol. Methods 144(1-2), 1-11 (2007).
20. Huang S, Salituro J, Tang N et al. Thermodynamically modulated partially double-stranded linear DNA probe design for homogeneous real-time PCR. Nucleic Acids Res. 35(16), E101-E108 (2007).
21. Swanson P, de Mendoza C, Joshi Y et al. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR vl.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. j. Clin. Microbiol. 43(8), 3860-3868 (2005).
22. Gao G, Buskell Z, Seeff L, Tabor E. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients. J. Med. Virol. 68(1), 60-67 (2002).
23. Swanson P, Huang S, Holzmayer V et al. Performance of the automated Abbott Realtime HIV-1 assay on a genetically diverse panel of specimens from Brazil. J. Virol. Methods 134(1-2), 237-243 (2006).
24. Swanson P, Holzmayer V, Huang S et al. Performance of the automated Abbott Realtime HIV-1 assay on a genetically diverse panel of specimens from London: comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx HIV RNA Quantitative assays. J. Virol. Methods 137(2), 184-192 (2006).
25. Swanson P, Huang S, Abravaya K et al. Evaluation of performance across the dynamic range of the Abbott Realtime HIV-1 assay as compared to VERSANT HIV-1 RNA 3.0 and AMPLICOR HIV-1 MONITOR vl.5 using serial dilutions of 39 group M and O viruses. J. Virol. Methods 141(1), 49-57 (2007).
26. Tang N, Huang S, Salituro J et al. A Realtime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples. J. Virol. Methods 146(1-2), 236-245 (2007).
27. Garcia-Diaz A, Clewley GS, Booth CL et al. Comparative evaluation of the performance of the Abbott real-time human immunodeficiency virus type 1 (HIV-1) assay for measurement of HIV-1 plasma viral load following automated specimen preparation. J. Clin. Microbiol. 44(5), 1788-1791 (2006).
28. Gueudin M, Plantier JC, Lemee V et al. Evaluation of the Roche Cobas TaqMan and Abbott Realtime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44(5), 500-505 (2007).
29. Michelin BD, Muller Z, Stelzl E, Marth E, Kessler HH. Evaluation of the Abbott Realtime HCV assay for quantitative detection of hepatitis C virus RNA. J. Clin. Virol. 38(2), 96-100 (2007).
30. Schutten M, Fries E, Burghoorn-Maas C, Niesters HG. Evaluation of the analytical performance of the new Abbott Realtime RT-PCRs for the quantitative detection of HCV and HIV-1 RNA. J. Clin. Virol. 40(2), 99-104 (2007).
31. Tuaillon E, Mondain AM, Ottomani L et al. Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV Realtime assay [corrected] and VERSANT HCV RNA assay. J. Clin. Microbiol. 45(9), 3077-3081 (2007).
32. Wolff D, Gerritzen A. Comparison of the Roche COBAS Amplicor Monitor, Roche COBAS Ampliprep/COBAS Taqman and Abbott Realtime test assays for quantification of hepatitis C virus and HIV RNA. Clin. Chem. lab Med. 45(7), 917-922 (2007).
33. Fytili P, Tiemann C, Wang C et al. Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay. J. Clin. Virol. 39(4), 308-311 (2007).
34. Muller J, Eis-Hubinger AM, Daumer M et al. A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region. J. Virol. Methods 142(1-2), 127-135 (2007).
35. Braun P, Ehret R, Wiesmann F et al. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine. Clin. Chem. Lab. Med. 45(1), 93-99 (2007).
36. Halfon P, Bourliere M, Penaranda G, Khiri H, Ouzan D. Real-time PCR assays for hepatitis C virus (HCV) RNA quantitation are adequate for clinical management of patients with chronic HCV infection. J. Clin. Microbiol. 44(7), 2507-2511 (2006).
37. Damond F, Roquebert B, Benard A et al. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol. 45(10), 3436-3438 (2007).
38. Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method. Hematology 46(1), 22-31 (2007).
39. Wiedmann M, Kluwick S, Walter M et al. HIV-1, HCV and HBV seronegative window reduction by the new Roche Cobas TaqScreen MPX test in seroconverting donors. J. Clin. Virol. 39(4), 282-287 (2007).
40. Abbott RealTime™ HCV, package insert. Abbott Molecular, Inc., IL, USA.
41. Abbott RealTime™ HIV-1, Abbott Molecular, Inc., IL, USA.